CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a non-invasive method for early cancer detection in individuals with Lynch syndrome, a hereditary condition that increases cancer risk. By utilizing advanced technologies and artificial intelligence, it seeks to provide accessible and effective screening solutions for early-stage cancers.
We propose an ambitious yet well-conceived and deliverable pan-European, pan-cancer, pan-disciplinary, and multi-omic approach to address the pressing unmet need for an accurate, non-invasive, acceptable and cost-effective method of detecting precancerous and early-stage cancers in those individuals with Lynch syndrome (LS), the most common monogenetic increased hereditary cancer risk.
LS has historically been underfunded and underserved, leading to significant an inequality in access and treatm…
OSLO UNIVERSITETSSYKEHUS HF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Finland, Tampere
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Edinburgh
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Paris
Type: Research institute
Activity type: Research Organisations
SME: No
Norway, Oslo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
